Ally Olotu is KEMRI-Wellcome Trust affiliate and works with Ifakara Health Institute in Bagamoyo, Tanzania. He has an MD degree from the University of Dar es salaam and DPhil in Clinical Medicine from the University of Oxford, UK. He currently heads the Department of Interventions and Clinical Trials at Ifakara Health Institute, and he is an adjunct faculty at the Nelson Mandela African Institute of Science and Technology teaching the master’s course in Public Health Research. In 2017, he was awarded an MRC African Research Leadership fellowship to work on a second-generation malaria vaccine candidate RH5 administered using viral vectors in Tanzanian children and infants in collaboration with Prof Simon Draper from the University of Oxford. Ally is currently an EDCTP senior fellow, working to establish blood-stage controlled human malaria infection and in-vivo transmission models for the evaluation blood-stage and transmission blocking vaccines respectively. He is also collaborating with Prof Philip Bejon and Mainga Hamaluba from KEMRI-Wellcome Trust Research Program, Prof Claudia Daubenberger from the Swiss Tropical Public Health Institute.